An association between TRP64ARG polymorphism of the B3 adrenoreceptor gene and some metabolic disturbances

Cardiovascular Diabetology

Volumn 10, Issue , 2011, Pages

  Mirrakhimov, Aibek E ^a,b   Kerimkulova, Alina S ^b   Lunegova, Olga S ^a   Moldokeeva, Cholpon B ^c   Zalesskaya, Yulia V ^a   Abilova, Samai S ^b   Sovhozova, Nurmira A ^d   Aldashev, Almaz A ^d   Mirrakhimov, Erkin M ^b  

^a National Centre of Cardiology and Internal medicine named by M Mirrakhimov   (Kyrgyzstan)

^b Kyrgyz State Medical Academy   (Kyrgyzstan)

^c KYRGYZ RUSSIAN SLAVIC UNIVERSITY   (Kyrgyzstan)

^d Institute of Molecular Biology and Medicine   (Kyrgyzstan)

Author keywords

Abdominal obesity; B adrenoreceptors; Dyslipidemia; Metabolic syndrome; Trp64arg polymorphism

Indexed keywords

BETA 3 ADRENERGIC RECEPTOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ARGININE; TRYPTOPHAN;

ABDOMINAL OBESITY; ADULT; AGED; ALLELE; ANTHROPOMETRY; ARTICLE; DIABETES MELLITUS; ETHNIC GROUP; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOTE; HUMAN; HYPERTENSION; KYRGYZSTAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; OBESITY; PHYSICAL EXAMINATION; COMPARATIVE STUDY; ETHNOLOGY; GENETICS; METABOLIC SYNDROME X; METHODOLOGY; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS;

ADULT; AGED; ALLELES; ARGININE; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; KYRGYZSTAN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; POLYMORPHISM, GENETIC; RECEPTORS, ADRENERGIC, BETA-3; TRYPTOPHAN;

EID: 80053897421     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-10-89     Document Type: Article

References (40)

1. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung and Blood Institute scientific statement. Curr Opin Cardiol 2006, 21:1-6. 10.1097/01.hco.0000200416.65370.a0, 16355022.
2. Sattar N, Gaw A, Scherbakova O, Ford I, O'Reilly DS, Haffner SM, et al. Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003, 108:414-419. 10.1161/01.CIR.0000080897.52664.94, 12860911.
3. Lorenzo C, Okoloise M, Williams K, Stern MP, Haffner SM. The metabolic syndrome as predictor of type 2 diabetes: the San Antonio heart study. Diabetes Care 2003, 26:3153-3159. 10.2337/diacare.26.11.3153, 14578254.
4. Arner P. Hunting for human obesity genes? Look in the adipose tissue. Int J Obes Relat Metab Disord 2000, 24:S57-S62.
5. Zaagsma J, Nahorski SR. Is the adipocyte b-adrenoceptor a prototype for the recently cloned atypical b3-adrenoceptor?. Trends Pharmacol Sci 1990, 11:3-7. 10.1016/0165-6147(90)90032-4, 2155496.
6. Lofontan M, Berlan M. Fat cell adrenergic receptors and the control of white and brown fat cell function. J Lipid Res 1993, 34:1057-1091.
7. Katzmarzyk P, Perusse L, Bouchard C. Genetics of abdominal visceral fat levels. Am J Hum Biol 1999, 11:225-235. 10.1002/(SICI)1520-6300(1999)11:2<225::AID-AJHB10>3.0.CO;2-J, 11533946.
8. Krief S, Strosberg AD, Nyberg S, Emorine LJ, Arner P. Tissue distribution of B3-adrenergic receptor mRNA in man. J Clin Invest 1993, 91:344-349. 10.1172/JCI116191, 330032, 8380813.
9. Lönnqvist F, Thöme A, Nilsell K, Hoffstedt J, Arner P. A pathogenic role of visceral fat b3-adrenoceptors in obesity. J Clin Invest 1995, 95:1109-1116. 10.1172/JCI117758, 441447, 7883959.
10. Arch JRS, Kaumann AJ. B3 and atypical b-adrenoceptors. Med Res Rev 1993, 13:663-729. 10.1002/med.2610130604, 8258999.
11. Clement K, Manning BS, Basdevant A, Strosberg AD, Guy-Grand B, Froguel P. Gender effect of theTrp64Arg mutation in the b3-adrenergic receptor gene on weight gain in morbid obesity. Diabetes Metab 1997, 23:424-427.
12. Li LS, Lönnqvist F, Luthman H, Arner P. Phenotypic characterization of the Trp64Arg polymorphism in the b3-adrenergic receptor gene in normal weight and obese subjects. Diabetologia 1996, 39:857-860.
13. Walston J, Silver K, Bogardus C, Knowler WC, Celi FS, Austin S, et al. Time of onset of non-insulin-dependent diabetes mellitus and genetic variation in the b3-adrenergic-receptor-gene. N Engl J Med 1995, 333:343-347. 10.1056/NEJM199508103330603, 7609750.
14. Walston J, Silver K, Hilfiker H, Andersen RE, Seibert M, BeamerBet A. Insulin response to glucose is lower in individuals homozygous for the Arg64 variant of the beta-3-adrenergic receptor. J Clin Endocrinol Metab 2000, 85:4019-4022. 10.1210/jc.85.11.4019, 11095426.
15. Perfetti R, Hui H, Chamie K, Binder S, Seibert M, McLenithan J, et al. Pancreatic beta-cells expressing the Arg64 variant of the beta(3)-adrenergic receptor exhibit abnormal insulin secretory activity. J Mol Endocrinol 2001, 27:133-144. 10.1677/jme.0.0270133, 11564599.
16. Kadowaki H, Yasuda K, Iwamoto K, Otabe S, Shimokawa K, Silver K, et al. A mutation in the b3-adrenergic receptor gene is associated with obesity and hyperinsulinemia in Japanese subjects. Biochem Biophys Res Commun 1995, 215:555-560. 10.1006/bbrc.1995.2500, 7487991.
17. Widen E, Lehto M, Kanninen T, Walston J, Shuldiner AR, Groop LC. Association of a polymorphism in the B3-adrenergic receptor gene with features of the insulin resistance syndrome in Finns. N Engl J Med 1995, 333:348-351. 10.1056/NEJM199508103330604, 7609751.
18. Kurabayashi T, Carey DGP, Morrison NA. The B3 adrenergic receptor gene Trp64Arg mutation is over presented in obese women: effects on weight, BMI, abdominal fat, blood pressure, and reproductive history in an elderly Australian population. Diabetes 1996, 45:1358-1363. 10.2337/diabetes.45.10.1358, 8826971.
19. Proenza AM, Poissonnet CM, Ozata M, Ozen S, Guran S, Palou A, et al. Association of sets of alleles of genes encoding b3-adrenoreceptor, uncoupling protein 1 and lipoprotein lipase with increased risk of metabolic complications in obesity. Int J Obes Relat Metab Disord 2000, 24:93-100. 10.1038/sj.ijo.0801091, 10702757.
20. Oeveren van-Dybicz AM, Vonkeman HE, Bon MA, van den Bergh FA, Vermes I. B3-adrenergic receptor gene polymorphism and type 2 diabetes in a Caucasian population. Diabetes Obes Metab 2001, 3:47-51. 10.1046/j.1463-1326.2001.00121.x, 11213599.
21. Awata T, Katayama S. Genetic variation in the b3-adrenergic receptor in Japanese NIDDM patients. Diabetes Care 1996, 19:271-272.
22. Gagnon J, Mauriege P, Roy S, Sjostrom D, Chagnon YC, Dionne FT, et al. The Trp64Argmutationof the b3-adrenergic receptor gene has no effect on obesity phenotypes in the Quebec family study and Swedish obese subjects cohorts. J Clin Invest 1996, 98:2086-2093. 10.1172/JCI119014, 507653, 8903328.
23. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972, 18:499-502.
24. Astrup A, Buemann B, Toubro S. Fat metabolism in the prediction to obesity. Ann NY Acad Sci 1997, 827:417-428. 10.1111/j.1749-6632.1997.tb51852.x, 9329772.
25. Strazzullo P, Iacone R, Siani A, Cappuccio FP, Russo O, Barba G, et al. Relationship of Trp64Arg polymorphism of the beta3 adrenoceptor gene to central adiposity and high blood pressure: interaction with age. Cross-sectional and longitudinal findings of the Olivetti prospective heart study. J Hypertens 2001, 19:399-406. 10.1097/00004872-200103000-00007, 11288809.
26. Büettner R, Schäffler A, Arndt H, Rogler G, Nusser J, Zietz B, et al. The Trp64Arg polymorphism of the b3-adrenergic receptor gene is not associated with obesity or type 2 diabetes mellitus in a large population-based Caucasian cohort. J Clin Endocrinol Metab 1998, 83:2892-2897. 10.1210/jc.83.8.2892, 9709965.
27. Ghosh S, Langefeld CD, Ally D, Watanabe RM, Hauser ER, Magnuson VL, et al. The W64R variant of the b3-adrenergic receptor is not associated with type II diabetes or obesity in a large Finnish sample. Diabetologia 1999, 42:238-244. 10.1007/s001250051144, 10064105.
28. Fujisawa T, Ikegami H, Kawaguchi Y, Ogihara T. Meta-analysis of the association of Trp64Arg polymorphism of beta 3-adrenergic receptor gene with body mass index. J Clin Endocrinol Metab 1998, 83:2441-2444. 10.1210/jc.83.7.2441, 9661625.
29. Kurokawa N, Nakai K, Kameo S, Liu ZM, Satoh H. Association of BMI with the b3-adrenergic receptor gene polymorphism in Japanese: meta-analysis. Obes Res 2001, 9:741-5. 10.1038/oby.2001.102, 11743057.
30. Walston J, Silver K, Shuldiner AR. The B3-adrenergic receptor and susceptibility to obesity, the insulin resistance syndrome, and non-insulin-dependent diabetes mellitus. 1997, 301-318. Contemporary Endocrinology: G Proteins, Receptors, and Disease. Totowa, NJ: Humana Press Inc., Spiegel AM.
31. Malczewska-Malec M, Wybrańska I, Leszczyńska-Gołabek I, Niedbał S, Kwaśniak M, Hartwich J, et al. An analysis of the link between polymorphisms of the beta2 and beta3 adrenergic receptor gene and metabolic parameters among Polish Caucasians with familial obesity. Med Sci Monit 2003, 9(6):CR 225-234.
32. Urhammer SA, Clausen JO, Hansen T, Pedersen O. Insulin sensitivity and body weight changes in young white carriers of the codon64 amino acid polymorphism of the B3-adrenergic receptor gene. Diabetes 1996, 45:1115-1120. 10.2337/diabetes.45.8.1115, 8690160.
33. Büettner R, Schäffler A, Arndt H, Rogler G, Nusser J, Zietz B, et al. The Trp64Arg polymorphism of the b3-adrenergic receptor gene is not associated with obesity or type 2 diabetes mellitus in a large population-based Caucasian cohort. J Clin Endocrinol Metab 1998, 83:2892-2897. 10.1210/jc.83.8.2892, 9709965.
34. Fujisawa T, Ikegami H, Yamato E, Takekawa K, Nakagawa Y, Hamada Y, et al. Association of Trp64Arg mutation of the b3-adrenergic-receptor with type 2 diabetes and body weight gain. Diabetologia 1996, 39:349-52. 10.1007/BF00418352, 8721782.
35. Shen YT, Zhang H, Vatner SF. Peripheral vascular effects of B3-adrenergic receptor stimulation in conscious dogs. J Pharmacol Exp Ther 1994, 268:466-473.
36. Tonolo G, Melis MG, Secchi G, Atzeni MM, Angius MF, Carboni A, et al. Association of Trp64Arg B3-Adrenergic-receptor gene polymorphism with essential hypertension in the Sardinian population. J Hypertens 1999, 17:33-38. 10.1097/00004872-199917010-00006, 10100091.
37. Iwamoto Y, Ohishi M, Yuan M, Tatara Y, Kato N, Takeya Y, et al. B-Adrenergic receptor gene polymorphism is a genetic risk factor for cardiovascular disease: a cohort study with hypertensive patients. Hypertens Res 2011, 34(5):573-577. 10.1038/hr.2010.281, 21289629.
38. Hakalahti AE, Tapanainen JM, Junttila JM, Kaikkonen KS, Huikuri HV, Petäjä-Repo UE. Association of the Beta-1 adrenergic receptor carboxyl terminal variants with left ventricular hypertrophy among diabetic and non-diabetic survivors of acute myocardial infarction. Cardiovasc Diabetol 2010, 9:42. 10.1186/1475-2840-9-42, 2933672, 20731869.
39. Urhammer SA, Clausen JO, Hansen T, Pedersen O. Insulin sensitivity and body weight changes in young white carriers of the codon64 amino acid polymorphism of the B3-adrenergic receptor gene. Diabetes 1996, 45:1115-1120. 10.2337/diabetes.45.8.1115, 8690160.
40. Corella D, Guillern M, Portolers O, Sorli JV, Alonso V, Folch J, et al. Gender specific associations of the Trp64Arg mutation in the B3-adrenergic receptor gene with obesity-related phenotypes in a Mediterranean population: interaction with a common lipoprotein lipase gene variation. J Intern Med 2001, 25:348-360.